Entry Inhibitors in HIV Therapy
Edited by Jacqueline D. Reeves and Cynthia A. Derdeyn 2007 The entry of HIV into cellular targets is mediated by the envelope protein (Env) which studs the viral surface. A major milestone for inhibition of HIV entry was achieved in 2003 with the approval of the HIV fusion inhibitor enfuvirtide.
Continue reading →